Global Anatomic Pathology Market Research and Analysis 2015-2022
The Global anatomic pathology market is expected to grow at a CAGR of 6.8 % during 2017-2022. The branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically is known as Anatomic (or anatomical) pathology. The major application of anatomic pathology is to identify abnormalities that can help to diagnose and manage treatment of diseases. Although one of the frequent uses of anatomic pathology is to help identify and manage various types of cancerous tumors, it is also valuable in evaluating other conditions, including autoimmune disorders, kidney and liver diseases, and infections. In fact, in most hospitals, all tissue removed during surgery must be examined by a pathologist.
The global market is growing at a very fast pace owing to the increasing incidence and prevalence of chronic diseases including kidney or liver diseases, infectious diseases, and cancer. Cancer cases are growing exponentially around the world, with maximum patients suffering from colorectal, lung, prostate, and breast cancer. According to world cancer society in 2012 around 14.1 million new cases and 8.2 million cancer mortality were recorded this data is expected to boost by 21.7 million by 2030. Biomarkers are presenting a promising approach in the diagnosis of cancer and other diseases. The elevating use of biomarkers for the diagnosis of diseases is predicted to considerably accelerate the development of the anatomic pathology market. Apart from that, developing healthcare infrastructure and the growing elderly population also plays a contributing role, as elderly individuals are more prone to infectious diseases, thereby demanding proper diagnosis for effective treatment. Demand for anatomic pathology services is rising due to rising number of chronic diseases and therefore biopsies is also increasing. Any failure to deal with the large number of biopsies or comply with recommendations for cancer cases or other sample handling or additional testing may pose a major challenge. Improvement in turnaround time is another critical element of management, which act as a barrier in the growth of global anatomic pathology market.
Geographical Insights
Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. North America is having the highest market share of global market owing to increasing investments by government & academic research centers in diagnostic research, prevalence of lung cancer & other chronic diseases, growing elderly population, the presence of major players in this region and high attention to biomarkers research. Asia Pacific is expected to witness fastest market growth in the upcoming time period owing to rising population which directly increase chronic diseases, the presence of emerging economies such as India, China, and Japan, improved standards in health care services, growing demand for superior medical care, and the growing awareness regarding the importance of anatomic pathology investigation among health practitioners are some of the major factors which act as a motivator in the growth of APAC region.
Competitive Insights:
The Key Players in the Global anatomic pathology market Include Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, Abcam, Adnagen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, Autogenomics, Biocare Medical, Biocartis, Cellmax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, Rarecyte, Sakura Finetek Usa, Tecan, Volitionrx and so on Partnership, R&D, M&A, Product Launch Are The Key Strategy Adopted In The Global anatomic pathology market.
Market Segmentation:
Global anatomic pathology market is segmented on the basis of, application, product and services, end users and regional outlook.
1. Global Anatomic pathology Market Research And Analysis, By Application
2. Global Anatomic pathology Market Research And Analysis, By product and services
3. Global Anatomic pathology Market Research And Analysis, By End Users
4. Global Anatomic pathology Market Research And Analysis, By Subdivision
5. Global anatomic pathology market Research And Analysis, By Region
The global market is growing at a very fast pace owing to the increasing incidence and prevalence of chronic diseases including kidney or liver diseases, infectious diseases, and cancer. Cancer cases are growing exponentially around the world, with maximum patients suffering from colorectal, lung, prostate, and breast cancer. According to world cancer society in 2012 around 14.1 million new cases and 8.2 million cancer mortality were recorded this data is expected to boost by 21.7 million by 2030. Biomarkers are presenting a promising approach in the diagnosis of cancer and other diseases. The elevating use of biomarkers for the diagnosis of diseases is predicted to considerably accelerate the development of the anatomic pathology market. Apart from that, developing healthcare infrastructure and the growing elderly population also plays a contributing role, as elderly individuals are more prone to infectious diseases, thereby demanding proper diagnosis for effective treatment. Demand for anatomic pathology services is rising due to rising number of chronic diseases and therefore biopsies is also increasing. Any failure to deal with the large number of biopsies or comply with recommendations for cancer cases or other sample handling or additional testing may pose a major challenge. Improvement in turnaround time is another critical element of management, which act as a barrier in the growth of global anatomic pathology market.
Geographical Insights
Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. North America is having the highest market share of global market owing to increasing investments by government & academic research centers in diagnostic research, prevalence of lung cancer & other chronic diseases, growing elderly population, the presence of major players in this region and high attention to biomarkers research. Asia Pacific is expected to witness fastest market growth in the upcoming time period owing to rising population which directly increase chronic diseases, the presence of emerging economies such as India, China, and Japan, improved standards in health care services, growing demand for superior medical care, and the growing awareness regarding the importance of anatomic pathology investigation among health practitioners are some of the major factors which act as a motivator in the growth of APAC region.
Competitive Insights:
The Key Players in the Global anatomic pathology market Include Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, Abcam, Adnagen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, Autogenomics, Biocare Medical, Biocartis, Cellmax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, Rarecyte, Sakura Finetek Usa, Tecan, Volitionrx and so on Partnership, R&D, M&A, Product Launch Are The Key Strategy Adopted In The Global anatomic pathology market.
Market Segmentation:
Global anatomic pathology market is segmented on the basis of, application, product and services, end users and regional outlook.
1. Global Anatomic pathology Market Research And Analysis, By Application
2. Global Anatomic pathology Market Research And Analysis, By product and services
3. Global Anatomic pathology Market Research And Analysis, By End Users
4. Global Anatomic pathology Market Research And Analysis, By Subdivision
5. Global anatomic pathology market Research And Analysis, By Region
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. INCREASING NUMBER OF GERIATRIC POPULATION
3.2. RESTRAINT
3.2.1. STRINGENT REGULATIONS AND CHANGING REQUIREMENTS
3.2.2. US GOVERNMENT IMPOSES EXCISE DUTY
3.3. OPPORTUNITY
3.3.1. GROWING ASIA PACIFIC REGION
3.3.2. DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE
4. MARKET SEGMENTATION
4.1. ANATOMIC PATHOLOGY, BY APPLICATION
4.1.1. DISEASE DIAGNOSTIC
4.1.1.1. CANCER
4.1.1.2. LYMPHOMA
4.1.1.3. OTHERS
4.1.2. DRUG DISCOVERY
4.1.3. OTHERS
4.2. ANATOMIC PATHOLOGY, BY PRODUCT AND SERVICES
4.2.1. ANESTHESIOLOGY
4.2.2. CONSUMABLES
4.2.3. SERVICES
4.2.4. INSTRUMENTS
4.3. ANATOMIC PATHOLOGY, BY END USERS
4.3.1. HOSPITALS
4.3.2. CLINICAL LABORATORY
4.3.3. PHYSICIAN LABORATORY
4.3.4. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS
6.2.1. UK MARKET RESEARCH AND ANALYSIS
6.2.2. GERMANY MARKET RESEARCH AND ANALYSIS
6.2.3. SPAIN MARKET RESEARCH AND ANALYSIS
6.2.4. FRANCE MARKET RESEARCH AND ANALYSIS
6.2.5. ITALY MARKET RESEARCH AND ANALYSIS
6.2.6. ROE MARKET RESEARCH AND ANALYSIS
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS
7. COMPANY PROFILES
7.1. ABBOTT DIAGNOSTICS
7.1.1. INTRODUCTION
7.1.2. ABBOTT DIAGNOSTICS PRODUCT PORTFOLIO
7.1.3. ABBOTT DIAGNOSTICS RECENT ACTIVITIES
7.2. AGILENT TECHNOLOGIES
7.2.1. INTRODUCTION
7.2.2. AGILENT TECHNOLOGIES PRODUCT PORTFOLIO
7.2.3. AGILENT TECHNOLOGIES RECENT ACTIVITIES
7.3. DANAHER
7.3.1. INTRODUCTION
7.3.2. DANAHER PRODUCT PORTFOLIO
7.3.3. DANAHER RECENT ACTIVITIES
7.4. ROCHE DIAGNOSTICS
7.4.1. INTRODUCTION
7.4.2. ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
7.4.3. ROCHE DIAGNOSTICS RECENT ACTIVITIES
7.5. THERMO FISHER SCIENTIFIC
7.5.1. INTRODUCTION
7.5.2. THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
7.5.3. THERMO FISHER SCIENTIFIC RECENT ACTIVITIES
7.6. ABCAM
7.6.1. INTRODUCTION
7.6.2. ABCAM PRODUCT PORTFOLIO
7.6.3. ABCAM RECENT ACTIVITIES
7.7. ADNAGEN
7.7.1. INTRODUCTION
7.7.2. ADNAGEN PRODUCT PORTFOLIO
7.7.3. ADNAGEN RECENT ACTIVITIES
7.8. ADVANCED CELL DIAGNOSTICS
7.8.1. INTRODUCTION
7.8.2. ADVANCED CELL DIAGNOSTICS PRODUCT PORTFOLIO
7.8.3. ADVANCED CELL DIAGNOSTICS RECENT ACTIVITIES
7.9. AGENDIA
7.9.1. INTRODUCTION
7.9.2. AGENDIA PRODUCT PORTFOLIO
7.9.3. AGENDIA RECENT ACTIVITIES
7.10. ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY
7.10.1. INTRODUCTION
7.10.2. ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY PRODUCT PORTFOLIO
7.10.3. ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY RECENT ACTIVITIES
7.11. AUTOGENOMICS
7.11.1. INTRODUCTION
7.11.2. AUTOGENOMICS PRODUCT PORTFOLIO
7.11.3. AUTOGENOMICS RECENT ACTIVITIES
7.12. BIOCARE MEDICAL
7.12.1. INTRODUCTION
7.12.2. BIOCARE MEDICAL PRODUCT PORTFOLIO
7.12.3. BIOCARE MEDICAL RECENT ACTIVITIES
7.13. BIOCARTIS
7.13.1. INTRODUCTION
7.13.2. BIOCARTIS PRODUCT PORTFOLIO
7.13.3. BIOCARTIS RECENT ACTIVITIES
7.14. CELLMAX LIFE
7.14.1. INTRODUCTION
7.14.2. CELLMAX LIFE PRODUCT PORTFOLIO
7.14.3. CELLMAX LIFE RECENT ACTIVITIES
7.15. CANCER GENETICS
7.15.1. INTRODUCTION
7.15.2. CANCER GENETICS PRODUCT PORTFOLIO
7.15.3. CANCER GENETICS RECENT ACTIVITIES
7.16. DIGIPATH, ENZO BIOCHEM
7.16.1. INTRODUCTION
7.16.2. DIGIPATH, ENZO BIOCHEM PRODUCT PORTFOLIO
7.16.3. DIGIPATH, ENZO BIOCHEM RECENT ACTIVITIES
7.17. EPIC SCIENCES
7.17.1. INTRODUCTION
7.17.2. EPIC SCIENCES PRODUCT PORTFOLIO
7.17.3. EPIC SCIENCES RECENT ACTIVITIES
7.18. JANSSEN DIAGNOSTIC
7.18.1. INTRODUCTION
7.18.2. JANSSEN DIAGNOSTIC PRODUCT PORTFOLIO
7.18.3. JANSSEN DIAGNOSTIC RECENT ACTIVITIES
7.19. MONOGRAM BIOSCIENCES
7.19.1. INTRODUCTION
7.19.2. MONOGRAM BIOSCIENCES PRODUCT PORTFOLIO
7.19.3. MONOGRAM BIOSCIENCES RECENT ACTIVITIES
7.20. NUCLEIX, OMNYX
7.20.1. INTRODUCTION
7.20.2. NUCLEIX, OMNYX PRODUCT PORTFOLIO
7.20.3. NUCLEIX, OMNYX RECENT ACTIVITIES
7.21. OXFORD CANCER BIOMARKERS
7.21.1. INTRODUCTION
7.21.2. OXFORD CANCER BIOMARKERS PRODUCT PORTFOLIO
7.21.3. OXFORD CANCER BIOMARKERS RECENT ACTIVITIES
7.22. RARECYTE
7.22.1. INTRODUCTION
7.22.2. RARECYTE PRODUCT PORTFOLIO
7.22.3. RARECYTE RECENT ACTIVITIES
7.23. SAKURA FINETEK USA
7.23.1. INTRODUCTION
7.23.2. SAKURA FINETEK USA PRODUCT PORTFOLIO
7.23.3. SAKURA FINETEK USA RECENT ACTIVITIES
7.24. TECAN
7.24.1. INTRODUCTION
7.24.2. TECAN PRODUCT PORTFOLIO
7.24.3. TECAN RECENT ACTIVITIES
7.25. VOLITIONRX
7.25.1. INTRODUCTION
7.25.2. VOLITIONRX PRODUCT PORTFOLIO
7.25.3. VOLITIONRX RECENT ACTIVITIES
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. INCREASING NUMBER OF GERIATRIC POPULATION
3.2. RESTRAINT
3.2.1. STRINGENT REGULATIONS AND CHANGING REQUIREMENTS
3.2.2. US GOVERNMENT IMPOSES EXCISE DUTY
3.3. OPPORTUNITY
3.3.1. GROWING ASIA PACIFIC REGION
3.3.2. DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE
4. MARKET SEGMENTATION
4.1. ANATOMIC PATHOLOGY, BY APPLICATION
4.1.1. DISEASE DIAGNOSTIC
4.1.1.1. CANCER
4.1.1.2. LYMPHOMA
4.1.1.3. OTHERS
4.1.2. DRUG DISCOVERY
4.1.3. OTHERS
4.2. ANATOMIC PATHOLOGY, BY PRODUCT AND SERVICES
4.2.1. ANESTHESIOLOGY
4.2.2. CONSUMABLES
4.2.3. SERVICES
4.2.4. INSTRUMENTS
4.3. ANATOMIC PATHOLOGY, BY END USERS
4.3.1. HOSPITALS
4.3.2. CLINICAL LABORATORY
4.3.3. PHYSICIAN LABORATORY
4.3.4. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS
6.2.1. UK MARKET RESEARCH AND ANALYSIS
6.2.2. GERMANY MARKET RESEARCH AND ANALYSIS
6.2.3. SPAIN MARKET RESEARCH AND ANALYSIS
6.2.4. FRANCE MARKET RESEARCH AND ANALYSIS
6.2.5. ITALY MARKET RESEARCH AND ANALYSIS
6.2.6. ROE MARKET RESEARCH AND ANALYSIS
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS
7. COMPANY PROFILES
7.1. ABBOTT DIAGNOSTICS
7.1.1. INTRODUCTION
7.1.2. ABBOTT DIAGNOSTICS PRODUCT PORTFOLIO
7.1.3. ABBOTT DIAGNOSTICS RECENT ACTIVITIES
7.2. AGILENT TECHNOLOGIES
7.2.1. INTRODUCTION
7.2.2. AGILENT TECHNOLOGIES PRODUCT PORTFOLIO
7.2.3. AGILENT TECHNOLOGIES RECENT ACTIVITIES
7.3. DANAHER
7.3.1. INTRODUCTION
7.3.2. DANAHER PRODUCT PORTFOLIO
7.3.3. DANAHER RECENT ACTIVITIES
7.4. ROCHE DIAGNOSTICS
7.4.1. INTRODUCTION
7.4.2. ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
7.4.3. ROCHE DIAGNOSTICS RECENT ACTIVITIES
7.5. THERMO FISHER SCIENTIFIC
7.5.1. INTRODUCTION
7.5.2. THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
7.5.3. THERMO FISHER SCIENTIFIC RECENT ACTIVITIES
7.6. ABCAM
7.6.1. INTRODUCTION
7.6.2. ABCAM PRODUCT PORTFOLIO
7.6.3. ABCAM RECENT ACTIVITIES
7.7. ADNAGEN
7.7.1. INTRODUCTION
7.7.2. ADNAGEN PRODUCT PORTFOLIO
7.7.3. ADNAGEN RECENT ACTIVITIES
7.8. ADVANCED CELL DIAGNOSTICS
7.8.1. INTRODUCTION
7.8.2. ADVANCED CELL DIAGNOSTICS PRODUCT PORTFOLIO
7.8.3. ADVANCED CELL DIAGNOSTICS RECENT ACTIVITIES
7.9. AGENDIA
7.9.1. INTRODUCTION
7.9.2. AGENDIA PRODUCT PORTFOLIO
7.9.3. AGENDIA RECENT ACTIVITIES
7.10. ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY
7.10.1. INTRODUCTION
7.10.2. ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY PRODUCT PORTFOLIO
7.10.3. ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY RECENT ACTIVITIES
7.11. AUTOGENOMICS
7.11.1. INTRODUCTION
7.11.2. AUTOGENOMICS PRODUCT PORTFOLIO
7.11.3. AUTOGENOMICS RECENT ACTIVITIES
7.12. BIOCARE MEDICAL
7.12.1. INTRODUCTION
7.12.2. BIOCARE MEDICAL PRODUCT PORTFOLIO
7.12.3. BIOCARE MEDICAL RECENT ACTIVITIES
7.13. BIOCARTIS
7.13.1. INTRODUCTION
7.13.2. BIOCARTIS PRODUCT PORTFOLIO
7.13.3. BIOCARTIS RECENT ACTIVITIES
7.14. CELLMAX LIFE
7.14.1. INTRODUCTION
7.14.2. CELLMAX LIFE PRODUCT PORTFOLIO
7.14.3. CELLMAX LIFE RECENT ACTIVITIES
7.15. CANCER GENETICS
7.15.1. INTRODUCTION
7.15.2. CANCER GENETICS PRODUCT PORTFOLIO
7.15.3. CANCER GENETICS RECENT ACTIVITIES
7.16. DIGIPATH, ENZO BIOCHEM
7.16.1. INTRODUCTION
7.16.2. DIGIPATH, ENZO BIOCHEM PRODUCT PORTFOLIO
7.16.3. DIGIPATH, ENZO BIOCHEM RECENT ACTIVITIES
7.17. EPIC SCIENCES
7.17.1. INTRODUCTION
7.17.2. EPIC SCIENCES PRODUCT PORTFOLIO
7.17.3. EPIC SCIENCES RECENT ACTIVITIES
7.18. JANSSEN DIAGNOSTIC
7.18.1. INTRODUCTION
7.18.2. JANSSEN DIAGNOSTIC PRODUCT PORTFOLIO
7.18.3. JANSSEN DIAGNOSTIC RECENT ACTIVITIES
7.19. MONOGRAM BIOSCIENCES
7.19.1. INTRODUCTION
7.19.2. MONOGRAM BIOSCIENCES PRODUCT PORTFOLIO
7.19.3. MONOGRAM BIOSCIENCES RECENT ACTIVITIES
7.20. NUCLEIX, OMNYX
7.20.1. INTRODUCTION
7.20.2. NUCLEIX, OMNYX PRODUCT PORTFOLIO
7.20.3. NUCLEIX, OMNYX RECENT ACTIVITIES
7.21. OXFORD CANCER BIOMARKERS
7.21.1. INTRODUCTION
7.21.2. OXFORD CANCER BIOMARKERS PRODUCT PORTFOLIO
7.21.3. OXFORD CANCER BIOMARKERS RECENT ACTIVITIES
7.22. RARECYTE
7.22.1. INTRODUCTION
7.22.2. RARECYTE PRODUCT PORTFOLIO
7.22.3. RARECYTE RECENT ACTIVITIES
7.23. SAKURA FINETEK USA
7.23.1. INTRODUCTION
7.23.2. SAKURA FINETEK USA PRODUCT PORTFOLIO
7.23.3. SAKURA FINETEK USA RECENT ACTIVITIES
7.24. TECAN
7.24.1. INTRODUCTION
7.24.2. TECAN PRODUCT PORTFOLIO
7.24.3. TECAN RECENT ACTIVITIES
7.25. VOLITIONRX
7.25.1. INTRODUCTION
7.25.2. VOLITIONRX PRODUCT PORTFOLIO
7.25.3. VOLITIONRX RECENT ACTIVITIES
LIST OF TABLES
Table # 1 GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
Table # 2 GLOBAL DISEASE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 3 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 4 GLOBAL LYMPHOMA MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 5 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 6 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 7 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 8 GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS, BY PRODUCT AND SERVICES 2015-2022 ($ MILLION)
Table # 9 GLOBAL ANESTHESIOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 10 GLOBAL CONSUMABLES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 11 GLOBAL SERVICES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 12 GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 13 GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS, BY END USERS 2015-2022 ($ MILLION)
Table # 14 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 15 GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 16 GLOBAL PHYSICIAN LABORATORY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 17 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 18 ABBOTT DIAGNOSTICS PRODUCT PORTFOLIO
Table # 19 ABBOTT DIAGNOSTICS RECENT ACTIVITIES
Table # 20 AGILENT TECHNOLOGIES PRODUCT PORTFOLIO
Table # 21 AGILENT TECHNOLOGIES RECENT ACTIVITIES
Table # 22 DANAHER PRODUCT PORTFOLIO
Table # 23 DANAHER RECENT ACTIVITIES
Table # 24 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
Table # 25 ROCHE DIAGNOSTICS RECENT ACTIVITIES
Table # 26 THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
Table # 27 THERMO FISHER SCIENTIFIC RECENT ACTIVITIES
Table # 28 ABCAM PRODUCT PORTFOLIO
Table # 29 ABCAM RECENT ACTIVITIES
Table # 30 ADNAGEN PRODUCT PORTFOLIO
Table # 31 ADNAGEN RECENT ACTIVITIES
Table # 32 ADVANCED CELL DIAGNOSTICS PRODUCT PORTFOLIO
Table # 33 ADVANCED CELL DIAGNOSTICS RECENT ACTIVITIES
Table # 34 AGENDIA PRODUCT PORTFOLIO
Table # 35 AGENDIA RECENT ACTIVITIES
Table # 36 ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY PRODUCT PORTFOLIO
Table # 37 ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY RECENT ACTIVITIES
Table # 38 AUTOGENOMICS PRODUCT PORTFOLIO
Table # 39 AUTOGENOMICS RECENT ACTIVITIES
Table # 40 BIOCARE MEDICAL PRODUCT PORTFOLIO
Table # 41 BIOCARE MEDICAL RECENT ACTIVITIES
Table # 42 BIOCARTIS PRODUCT PORTFOLIO
Table # 43 BIOCARTIS RECENT ACTIVITIES
Table # 44 CELLMAX LIFE PRODUCT PORTFOLIO
Table # 45 CELLMAX LIFE RECENT ACTIVITIES
Table # 46 CANCER GENETICS PRODUCT PORTFOLIO
Table # 47 CANCER GENETICS RECENT ACTIVITIES
Table # 48 DIGIPATH, ENZO BIOCHEM PRODUCT PORTFOLIO
Table # 49 DIGIPATH, ENZO BIOCHEM RECENT ACTIVITIES
Table # 50 EPIC SCIENCES PRODUCT PORTFOLIO
Table # 51 EPIC SCIENCES RECENT ACTIVITIES
Table # 52 JANSSEN DIAGNOSTIC PRODUCT PORTFOLIO
Table # 53 JANSSEN DIAGNOSTIC RECENT ACTIVITIES
Table # 54 MONOGRAM BIOSCIENCES PRODUCT PORTFOLIO
Table # 55 MONOGRAM BIOSCIENCES RECENT ACTIVITIES
Table # 56 NUCLEIX, OMNYX PRODUCT PORTFOLIO
Table # 57 NUCLEIX, OMNYX RECENT ACTIVITIES
Table # 58 OXFORD CANCER BIOMARKERS PRODUCT PORTFOLIO
Table # 59 OXFORD CANCER BIOMARKERS RECENT ACTIVITIES
Table # 60 RARECYTE PRODUCT PORTFOLIO
Table # 61 RARECYTE RECENT ACTIVITIES
Table # 62 SAKURA FINETEK USA PRODUCT PORTFOLIO
Table # 63 SAKURA FINETEK USA RECENT ACTIVITIES
Table # 64 TECAN PRODUCT PORTFOLIO
Table # 65 TECAN RECENT ACTIVITIES
Table # 66 VOLITIONRX PRODUCT PORTFOLIO
Table # 67 VOLITIONRX RECENT ACTIVITIES
Table # 1 GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
Table # 2 GLOBAL DISEASE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 3 GLOBAL CANCER MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 4 GLOBAL LYMPHOMA MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 5 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 6 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 7 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 8 GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS, BY PRODUCT AND SERVICES 2015-2022 ($ MILLION)
Table # 9 GLOBAL ANESTHESIOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 10 GLOBAL CONSUMABLES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 11 GLOBAL SERVICES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 12 GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 13 GLOBAL ANATOMIC PATHOLOGY MARKET RESEARCH AND ANALYSIS, BY END USERS 2015-2022 ($ MILLION)
Table # 14 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 15 GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 16 GLOBAL PHYSICIAN LABORATORY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 17 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 18 ABBOTT DIAGNOSTICS PRODUCT PORTFOLIO
Table # 19 ABBOTT DIAGNOSTICS RECENT ACTIVITIES
Table # 20 AGILENT TECHNOLOGIES PRODUCT PORTFOLIO
Table # 21 AGILENT TECHNOLOGIES RECENT ACTIVITIES
Table # 22 DANAHER PRODUCT PORTFOLIO
Table # 23 DANAHER RECENT ACTIVITIES
Table # 24 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
Table # 25 ROCHE DIAGNOSTICS RECENT ACTIVITIES
Table # 26 THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
Table # 27 THERMO FISHER SCIENTIFIC RECENT ACTIVITIES
Table # 28 ABCAM PRODUCT PORTFOLIO
Table # 29 ABCAM RECENT ACTIVITIES
Table # 30 ADNAGEN PRODUCT PORTFOLIO
Table # 31 ADNAGEN RECENT ACTIVITIES
Table # 32 ADVANCED CELL DIAGNOSTICS PRODUCT PORTFOLIO
Table # 33 ADVANCED CELL DIAGNOSTICS RECENT ACTIVITIES
Table # 34 AGENDIA PRODUCT PORTFOLIO
Table # 35 AGENDIA RECENT ACTIVITIES
Table # 36 ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY PRODUCT PORTFOLIO
Table # 37 ANGSANA MOLECULAR & DIAGNOSTICS LABORATORY RECENT ACTIVITIES
Table # 38 AUTOGENOMICS PRODUCT PORTFOLIO
Table # 39 AUTOGENOMICS RECENT ACTIVITIES
Table # 40 BIOCARE MEDICAL PRODUCT PORTFOLIO
Table # 41 BIOCARE MEDICAL RECENT ACTIVITIES
Table # 42 BIOCARTIS PRODUCT PORTFOLIO
Table # 43 BIOCARTIS RECENT ACTIVITIES
Table # 44 CELLMAX LIFE PRODUCT PORTFOLIO
Table # 45 CELLMAX LIFE RECENT ACTIVITIES
Table # 46 CANCER GENETICS PRODUCT PORTFOLIO
Table # 47 CANCER GENETICS RECENT ACTIVITIES
Table # 48 DIGIPATH, ENZO BIOCHEM PRODUCT PORTFOLIO
Table # 49 DIGIPATH, ENZO BIOCHEM RECENT ACTIVITIES
Table # 50 EPIC SCIENCES PRODUCT PORTFOLIO
Table # 51 EPIC SCIENCES RECENT ACTIVITIES
Table # 52 JANSSEN DIAGNOSTIC PRODUCT PORTFOLIO
Table # 53 JANSSEN DIAGNOSTIC RECENT ACTIVITIES
Table # 54 MONOGRAM BIOSCIENCES PRODUCT PORTFOLIO
Table # 55 MONOGRAM BIOSCIENCES RECENT ACTIVITIES
Table # 56 NUCLEIX, OMNYX PRODUCT PORTFOLIO
Table # 57 NUCLEIX, OMNYX RECENT ACTIVITIES
Table # 58 OXFORD CANCER BIOMARKERS PRODUCT PORTFOLIO
Table # 59 OXFORD CANCER BIOMARKERS RECENT ACTIVITIES
Table # 60 RARECYTE PRODUCT PORTFOLIO
Table # 61 RARECYTE RECENT ACTIVITIES
Table # 62 SAKURA FINETEK USA PRODUCT PORTFOLIO
Table # 63 SAKURA FINETEK USA RECENT ACTIVITIES
Table # 64 TECAN PRODUCT PORTFOLIO
Table # 65 TECAN RECENT ACTIVITIES
Table # 66 VOLITIONRX PRODUCT PORTFOLIO
Table # 67 VOLITIONRX RECENT ACTIVITIES
LIST OF FIGURES
Figure # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 6 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 7 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 8 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 9 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 6 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 7 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 8 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 9 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
